or Try an Advanced Search...

    Technical Analysis for FHTX - Foghorn Therapeutics Inc.

    Grade Last Price % Change Price Change
    C 8.06 2.48% 0.20
    FHTX closed up 0.77 percent on Wednesday, November 20, 2024, on 46 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical FHTX trend table...
    Date Alert Name Type % Chg
    MACD Bearish Centerline Cross Bearish 2.48%
    NR7 Range Contraction 2.48%
    NR7-2 Range Contraction 2.48%
    Stochastic Reached Oversold Weakness 2.48%
    Oversold Stochastic Weakness 2.48%
    NR7 Range Contraction 3.27%
    Inside Day Range Contraction 3.27%
    MACD Bearish Signal Line Cross Bearish 4.47%
    Inside Day Range Contraction 4.47%
    Down 3 Days in a Row Weakness 4.47%
    Older End-of-Day Signals for FHTX ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 3 hours ago
    Rose Above Previous Day's High about 4 hours ago
    Up 3% about 4 hours ago
    Up 2% about 4 hours ago
    Up 1% about 4 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    FHTX Chart by TradingView
    Basic chart:

    Profile

    Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control™ platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The company is developing multiple product candidates in oncology and expects to file an IND for its first program later this year.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Biology Medication

    Is FHTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 12 Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
    Nov 7 Analysts Have Made A Financial Statement On Foghorn Therapeutics Inc.'s (NASDAQ:FHTX) Third-Quarter Report
    Nov 6 We Think Foghorn Therapeutics (NASDAQ:FHTX) Needs To Drive Business Growth Carefully
    Nov 4 Foghorn Therapeutics GAAP EPS of -$0.31 beats by $0.13, revenue of $7.81M beats by $0.8M
    Nov 4 Foghorn Therapeutics Inc. (FHTX) Reports Q3 Loss, Misses Revenue Estimates
    Nov 4 Foghorn Therapeutics Provides Third Quarter 2024 Financial and Corporate Update
    Oct 23 Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence
    Oct 11 Foghorn Therapeutics Unveils Clinical Pipeline Progress
    Oct 10 Foghorn Therapeutics Announces First Patient Dosed with First-in-Class Oral SMARCA2 Selective Inhibitor FHD-909 in a Phase 1 Trial for SMARCA4 Mutated Solid Tumors
    Oct 7 BeiGene (BGNE) Moves 5.3% Higher: Will This Strength Last?
    See more FHTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.25
    52 Week Low 2.7
    Average Volume 169,158
    200-Day Moving Average 6.84
    50-Day Moving Average 8.43
    20-Day Moving Average 8.38
    10-Day Moving Average 8.56
    Average True Range 0.66
    RSI (14) 43.82
    ADX 20.69
    +DI 16.26
    -DI 21.39
    Chandelier Exit (Long, 3 ATRs) 7.73
    Chandelier Exit (Short, 3 ATRs) 9.11
    Upper Bollinger Bands 9.56
    Lower Bollinger Band 7.20
    Percent B (%b) 0.28
    BandWidth 28.18
    MACD Line 0.00
    MACD Signal Line 0.12
    MACD Histogram -0.119
    Fundamentals Value
    Market Cap 331.83 Million
    Num Shares 42.2 Million
    EPS -2.46
    Price-to-Earnings (P/E) Ratio -3.20
    Price-to-Sales 8.40
    Price-to-Book 10.71
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 8.54
    Resistance 3 (R3) 8.52 8.29 8.42
    Resistance 2 (R2) 8.29 8.11 8.29 8.38
    Resistance 1 (R1) 8.07 8.01 8.18 8.09 8.35
    Pivot Point 7.84 7.84 7.89 7.84 7.84
    Support 1 (S1) 7.62 7.66 7.73 7.64 7.37
    Support 2 (S2) 7.39 7.56 7.39 7.34
    Support 3 (S3) 7.17 7.39 7.30
    Support 4 (S4) 7.19